Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fusing genes could hold leukaemia treatment clues

17.11.2006
Pioneering cancer scientists at The University of Nottingham are to investigate why a rare form of leukaemia is triggered when two genes fuse together.

It is hoped the research will lead to the discovery of potential new drugs to treat the rare form of acute myeloid leukaemia, which currently affects 2,000 adults and more than 100 children in the UK every year.

Professor David Heery and Dr Karin Kindle in the University’s School of Pharmacy have been awarded a £150,000 grant from the AICR (Association of International Cancer Research) to study how the abnormal fusion of MOZ and TIF2 genes affects bone marrow cells and, by doing so, contributes to the development of the cancer.

Professor Heery, head of the Division of Molecular and Cellular Sciences, said: “At least 50 genes have been identified that are involved in gene fusions associated with leukaemia. The key question is to discover how MOZ-TIF2 and similar fusion proteins affect cell function.

... more about:
»Treatment »affect »leukaemia

“This will be critical in the future discovery of potential new drug treatments for patients with this form of the disease.”

AICR’s scientific adviser Dr Mark Matfield believes the work will have important implications in better understanding a type of leukaemia for which the exact causes are, as yet, unknown.

“This is an aggressive form of cancer and although it can affect all ages it is more common in older people, with slightly more reported cases in men. The main lab tests used in diagnosis are a full blood count and bone marrow biopsy,” he said.

“Without treatment AML will rapidly cause death, but with modern treatment protocols the cure rate has improved significantly in patients who are under 60. Older people tend to do less well, partly because they are often unable to receive the very intensive therapy needed for effective management of the disease.”

Derek Napier, AICR’s Chief Executive, said the grant was in line with the charity’s policy of funding the most exciting and novel approaches to research worldwide.

“We believe it important to fund work that pushes the boundaries and Professor Heery and Dr Kindle are charged with tackling a great scientific challenge that could in future change the lives of tens of thousands of people in the UK across the world.”

Emma Thorne | alfa
Further information:
http://www.nottingham.ac.uk

Further reports about: Treatment affect leukaemia

More articles from Life Sciences:

nachricht Discovery of a Key Regulatory Gene in Cardiac Valve Formation
24.05.2017 | Universität Basel

nachricht Carcinogenic soot particles from GDI engines
24.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

 
Latest News

A CLOUD of possibilities: Finding new therapies by combining drugs

24.05.2017 | Life Sciences

Carcinogenic soot particles from GDI engines

24.05.2017 | Life Sciences

A quantum walk of photons

24.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>